The first study of the safety and effectiveness of a coronavirus vaccine in Iran began Tuesday, state TV reported, with dozens due to receive the domestically developed shot in the hardest-hit country in the Middle East.
The vaccine, produced by Shifa Pharmed, part of a state-owned pharmaceutical conglomerate, is the first in the country to reach human trials. Rouhani has said Iran is cooperating with a “foreign country” to produce another vaccine expected to run in tests in volunteers in February, without offering further details.